title: Oral Acyclovir and Intralesional Interferon Injections for Treatment of Giant Pyogenic Granuloma-Like Lesions in an Immunocompromised Patient With Human Orf.
authors.affiliation: Department of Dermatology, Peking University First Hospital, Beijing, China2Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
authors.forename: Menglong
authors.initials: M
authors.lastname: Ran
authors.affiliation: Department of Dermatology, Peking University First Hospital, Beijing, China2Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
authors.forename: Mingyang
authors.initials: M
authors.lastname: Lee
authors.affiliation: Department of Dermatology, Peking University First Hospital, Beijing, China2Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China3Research Center for Medical Mycology, Peking University, Beijing, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Gong
authors.affiliation: Department of Dermatology, Peking University First Hospital, Beijing, China2Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
authors.forename: Zhimiao
authors.initials: Z
authors.lastname: Lin
authors.affiliation: Department of Dermatology, Peking University First Hospital, Beijing, China2Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China3Research Center for Medical Mycology, Peking University, Beijing, China.
authors.forename: Ruoyu
authors.initials: R
authors.lastname: Li
mesh_terms: D000212:Acyclovir / Q000008:administration & dosage*; D000284:Administration, Oral; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage; D001706:Biopsy; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004474:Ecthyma, Contagious / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D017789:Granuloma, Pyogenic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D015603:Keratinocytes / Q000648:ultrastructure; D008297:Male; D046529:Microscopy, Electron, Transmission; D011994:Recombinant Proteins / Q000008:administration & dosage; D012867:Skin / Q000473:pathology
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D000212:Acyclovir